We report on five patients presenting with features of two congenital disorders, DiGeorge syndrome (DGS) and CHARGE association. CHARGE association is usually sporadic and its origin is as yet unknown. Conversely, more than 90% of DGS patients are monosomic for the 22q11.2 chromosomal region. In each of the five patients, both cytogenetic and molecular analysis for the 22q11.2 region were normal. In view of the broad clinical spectrum and the likely genetic heterogeneity of both disorders, these cases are consistent with the extended phenotype of either DGS without 22ql1.2 deletion or CHARGE association, especially as several features of CHARGE association have been reported in rare patients with 22ql 1.2 deletion associated phenotypes. On the other hand, these could be novel cases of an independent association involving a complex defect of neural crest cells originating from the pharyngeal pouches.
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The ears were small, low set, and asymmetrical with an absent lobe ( fig 2B) and deafness confirmed by auditory evoked potentials. Unilateral facial nerve palsy and micrognathia were also observed. Additional features were a posterior cleft palate, proximally set thumbs, J and malposition of the toes. Cardiac repair was performed at the age of 1 month, followed by gastrostomy. At the age of 19 months, length and weight were -2 SD and head circumference -1. Patient 4 was a boy born at term by caesarean section because of acute fetal distress. He had DGS with thymic agenesis confirmed by mediastinal ultrasound, profoundly decreased T lymphocytes (total white blood cells 5000/ml, T lymphocytes 0%, normal range 6000-7200/ ml), hypocalcaemia on the first day of life (1.5 mmol/l) with low plasma parathyroid hormone (14.6 pg/ml), bicuspid aorta, and retrooesophageal left subclavian artery. He also had CHARGE association with right retinal coloboma, square face, malformed, low set ears, shallow orbital ridges ( fig 4A, B) , micropenis, and bilateral deafness confirmed by auditory evoked potentials. Additional features were left duplicated thumb and micrognathia. Velopharyngeal insufficiency and gastro-oesophageal reflux required tracheostomy with gastrostomy and Nissen procedure. At the age of 6 months, he had postnatal growth deficiency (both height and weight -4 SD). . s s i E d N : . . . . _ _ _ z i (table 2) favour the role of a de novo mutation or a subtle infracytogenetic chromosomal anomaly. In addition, we cannot exclude the possibility of genetic heterogeneity or phenocopies, and mutation screening should be undertaken in these patients once the molecular bases of DGS and CHARGE association are characterised. Finally, as far as prognosis is concerned, this new MCA/MR syndrome seems closer to CHARGE association than DGS, in particular with respect to severe feeding and respiratory problems. Two patients died during the first months of life and both neurological and psychomotor development were severly impaired in each of the survivors.
